Market Cap: $3.29B
UN
uniQure N.V.
QURE
NASDAQUSD
Market Cap: $3.29B
uniQure N.V. (Ticker: QURE) focuses on gene therapy for rare diseases and is currently in the spotlight due to a recent upsized public offering that raised approximately $259 million. This funding com…
uniQure N.V. (Ticker: QURE) is actively pioneering a promising gene therapy aimed at treating Mucopolysaccharidosis II (MPS II), a rare and devastating disorder affecting approximately 1 in 100,000 bi…
uniQure N.V. (Ticker: QURE) experiences a significant development following positive feedback from the U.S. Food and Drug Administration (FDA) regarding its gene therapy AMT-130. This therapy, aimed a…
uniQure N.V. (Ticker: QURE) prepares to advance its gene therapy aimed at Huntington's disease, following a constructive meeting with the FDA that provides a clearer regulatory path. The recent discus…
Open
$42.17
Prev. Close
$48.89
High
$42.89
Low
$41.57